Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
Articolo
Data di Pubblicazione:
2010
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
O'Connor, Cm; Miller, Ab; Blair, Je; Konstam, Ma; Wedge, P; Bahit, Mc; Carson, P; Haass, M; Hauptman, Pj; Metra, Marco; Oren, Rm; Patten, R; Piña, I; Roth, S; Sackner Bernstein, Jd; Traver, B; Cook, T; Gheorghiade, M.
Link alla scheda completa:
Pubblicato in: